PROTONVDA LLC
Proton computed tomography (pCT) and proton radiography (pRad) imaging system for real-time patient alignment and dose calculation in proton therapy
- Sector
- Medtech
- Total capital
- $4.2M
- Federal grants
- $4.2M
- 6 awards · 2015–2021
- Rank in peer group#202 of 538
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 4 pending · first 2021
- Rank in peer group#97 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · A Proton Tomography System for Optimization of Proton Therapy$913K
- Federal grantHealth and Human S · Phase II · A Proton Tomography System for Optimization of Proton Therapy$1.1M
- Federal grantHealth and Human S · Phase II · A Proton Radiography System for Optimization of Proton Therapy$718K
- Federal grantHealth and Human S · Phase II · A Proton Radiography System for Optimization of Proton Therapy$1.2M
- Federal grantHealth and Human S · Phase I · A Proton Radiography System for Optimization of Proton Therapy$40K
- Federal grantHealth and Human S · Phase I · A Proton Radiography System for Optimization of Proton Therapy$223K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#202 · top 38%
- Granted patents#97 · top 18%
- Linked publications#87 · top 16%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 6 granted of 10- GrantedUpdating Proton Stopping Power Maps For Proton Radiation Therapy Treatment PlanningUSPTOUS 12,403,329
- GrantedIterative Algorithm For Proton Ct Image ReconstructionUSPTOUS 11,908,045
- GrantedProcessing Pipeline For Prompt Particle Image ReconstructionUSPTOUS 11,813,105
Show all 10 patent records
- Updating Proton Stopping Power Maps For Proton Radiation Therapy Treatment PlanningSep 2, 2025 · US 12,403,329Granted
- Iterative Algorithm For Proton Ct Image ReconstructionFeb 20, 2024 · US 11,908,045Granted
- Processing Pipeline For Prompt Particle Image ReconstructionNov 14, 2023 · US 11,813,105Granted
- Proton Imaging System Incorporating Positron Emission Tomography (PET) Modules for Optimization of Proton TherapyAug 8, 2023 · US 11,717,237Granted
- Proton Imaging System For Optimization Of Proton TherapyJun 27, 2023 · US 11,684,328Granted
- Proton Imaging System For Optimization Of Proton TherapySep 14, 2021 · US 11,116,459Granted
- Processing Pipeline For Prompt Particle Image ReconstructionApplication PCTUS2018067628Pending
- Iterative Algorithm For Proton Ct Image ReconstructionApplication 63084424Pending
- Updating Proton Stopping Power Maps For Proton Radiation Therapy Treatment PlanningApplication 63415525Pending
- Proton Imaging System Incorporating Positron Emission Tomography (PET) Modules for Optimization of Proton TherapyApplication 63068580Pending
Recent research by its founders
- Feasibility study of using fast low-dose pencil beam proton and helium radiographs for intrafractional motion management20251 cites
- Feasibility study of using fast low-dose pencil beam proton and helium radiographs for intrafractional motion management20250 cites
- The potential of mixed carbon–helium beams for online treatment verification: a simulation and treatment planning study20245 cites
Related companies, and why
- ApiJect Holdings, Inc.Similar federal contract value in Medtech · null in contracts
- KORTUC INC.Similar federal contract value in Medtech · null in contracts
- POPNEURON LLCSimilar federal contract value in Medtech · null in contracts
- VAYU GLOBAL HEALTH INNOVATIONS, LLCSimilar federal contract value in Medtech · null in contracts
- Adagio MedicalSimilar federal contract value in Medtech · null in contracts
- Francis Medical, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .